Featured Stories
Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

The manufacturer of Plavix continues to be named in lawsuits alleging the blood thinner caused some patients to suffer from serious bleeding side effects. Most recently, the national law firm of Parker Waichman LLP filed nine Plavix bleeding lawsuits in state court in New York.

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

New Warning for Epidural Steroids Mandated by FDA

The U.S. Food and Drug Administration just announced that injectable corticosteroids must now contain a label warning concerning increased adverse events associated with epidural injections

Risks include death, stroke, permanent blindness, and permanent paralysis, the FDA indicated, according to MedPage Today. The warning followed an agency review of a number of reports in both the FDA Adverse Event Reporting System (FAERS) database and medical literature. In its warning, the FDA indicated that, “Serious adverse events included death, spinal cord infarction, paraplegia, quadriplegia, cortical blindness, stroke, seizures, nerve injury, and brain edema.” Continue reading

Posted in Health Concerns, Pharmaceuticals |

FDA Rules on E-Cigarettes Anticipated by Health Experts

FDA_Rules_on_E-CigarettesThe U.S. Food and Drug Administration (FDA) is expected to issue its first regulations on electronic cigarettes by the end of the month, NBC reports; many health experts are awaiting what the regulations will say. Many would like the new rules will strictly limit the e-cigarettes, which have brought up concerns among some who think they keep smokers addicted rather than help them quit, but are realistic about the actual outcome.   Continue reading

Posted in Legal News |

FDA Proposes Program to Expedite Access to High-Risk Medical Devices

FDA-Approvals-Medical-DevicesThe U.S. Food and Drug Administration is proposing a new program that would give earlier access to certain high-risk medical devices, but some are saying that the approach only benefits medical device companies. According to HealthData Management, the agency is seeking public comment on the proposal and is touting it as a “collaborative approach to facilitate product development under the agency’s existing regulatory authorities” that “seeks to reduce the time associated with product development” instead of current programs that have “focused on reducing the time for the premarket review.” Continue reading

Posted in Legal News |

Protease Inhibitors Used to Treat HIV May Increase Diabetes Risk

protease_inhibitors_may_increase_diabetesNew research suggests that patients with HIV using protease inhibitor regimens long term may have a higher risk of diabetes. The study, published in Diabetic Medicine, found that the HIV infection by itself does not seem to increase the risk of diabetes, however. Continue reading

Posted in Legal News |

Jury Awards Man $4 Million Over Mistaken Diagnosis, Related Surgery

Verdict_Against_Prominent_NeurologistA jury has awarded a man nearly $4 million in damages over an incorrect diagnosis and unnecessary surgery.

The man says he was disabled and is sick following treatments by neurologist Dr. Dale Lange, according to CBS New York. “I went through a lot of unnecessary stuff; a lot of pain; eventually lost my wife and family over all this—and I’m like, you know what? He did me wrong,” he said. Continue reading

Posted in Legal News, Malpractice |

Otterbox Settles Whistleblower Lawsuit for $4.3M

Otterbox_Settles_Lawsuit_for_$4.3MOtter Products LLC, the company that makes OtterBox smartphone and tablet cases, has settled a whistleblower lawsuit alleging that the company violated federal law by underpaying customs duties, North Colorado Business Report reports. According to U.S. Attorney John Walsh’s office, the company has paid $4.3 million to the U.S. government. The statement was announced Monday by the U.S. Attorney’s Office for the District of Colorado, Department of Homeland Security and U.S. Customs and Border Protection. Continue reading

Posted in Legal News |

Generic-Drug Failure Prompts FDA to take Action

FDA_takes_action_Generic_Drug_FailureGeneric drugs, non-name brand medications that cost far less than the brand-name, came under greater scrutiny recently after the U.S. Food and Drug Administration (FDA) banned imports of treatments made from two Indian facilities (Ranbaxy Labs and Wockhardy Ltd). The agency was forced to halt sale of generic drugs from these facilities due to drug safety. This spurred fear in the FDA and consumers alike, who are less likely to take generic drugs if they develop a reputation for being dangerous-even if they safe and just as effective. Generic medications make up nearly 80 percent of US prescriptions. Continue reading

Posted in Legal News |

Disabled Man Settles Delta Lawsuit, Alleges He Was Forced to Crawl On and Off Two Separate Flights

Disabled_Man_Settles_Delta_LawsuitA partially paralyzed man claims that Delta Airlines workers forced him to crawl on and off two flights in 2012. The lawsuit, brought in 2013, has just been settled.

The Maui man sued Delta over allegations that airline workers forced him to crawl on and off the flights the prior year and that the airline did not provide a wheelchair or other assistance on either of the 2012 flights, according to the Associated Press (AP). Continue reading

Posted in Legal News |

This Saturday is Prescription Drug Take-Back Day

DEA-National-Prescription-Drug-Take-Back-Day-April-2014National Prescription Drug Take-Back Day is scheduled for April 24th from 10:00 a.m. to 2:00 p.m., local time. The program seeks to offer a safe, convenient, and responsible way in which to dispose of prescription medications, according to the Department of Justice

The program is also meant to educate the general public about the potential likelihood of medication abuse, the Department of Justice indicates. Appropriately disposing of medications helps fight one of the key ways in which young people access drugs and develop substance abuse problems, wrote the Mercury News. Continue reading

Posted in Pharmaceuticals |

Study: Codeine Use in Children Poses Dangers

Codeine_Poses_Dangers_in_ChildrenAlthough there are recommended limits on codeine use in children, a new study reveals that codeine is prescribed to pediatric patients in at least 500,000 emergency room visits annually.

According to the decade-long study, in 2010 alone, 3 percent of pediatric emergency room visits led to a codeine prescription. With over 25 million ER visits involving children annually, too many children are being prescribed the painkiller, the study authors say, according to the Associated Press (AP). What’s more, there are better options available for children, the researchers note. Continue reading

Posted in Pharmaceuticals |